🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseWhat even is MASH? My doc mentioned it and I panicked Page 2

What even is MASH? My doc mentioned it and I panicked

nick_newbie Sun, May 17, 2026 at 1:44 AM 11 replies 492 viewsPage 2 of 3
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
May 18, 2026 at 1:30 AM#6
Dr.LipidDallas said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 319 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible…

Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

Baseline: "Moderate hepatic steatosis, liver span 17.2cm, echogenic texture consistent with fat infiltration"
Month 8: "Mild steatosis, liver span 15.8cm, improved echogenicity"
Month 14: "Minimal to no steatosis, normal liver span 14.5cm, normal echotexture"

My liver literally shrank and de-fattened. The ultrasound tech said she's seen this pattern increasingly in GLP-1 patients and it's remarkable how consistently the fatty liver resolves.

49 19Dr.ObesityLA, NurseKim_ATL, paul_denver and 46 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
May 18, 2026 at 10:58 AM#7
nick_newbie said:
Fatty liver on an incidental scan two years ago and nobody followed it up.

NASH/MAFLD therapeutic landscape and liver and MASH: GLP-1 agonists are emerging as potential first-line NASH therapy. The Phase 2b data for semaglutide showed 59% NASH resolution (vs 17% placebo) with 43% achieving fibrosis improvement[1].

Mechanism: GLP-1R activation reduces hepatic lipogenesis, increases fatty acid oxidation, reduces hepatic inflammation, and may directly reduce hepatic stellate cell activation (fibrosis pathway).

With resmetirom (thyroid hormone receptor agonist) recently approved for NASH, the field is evolving rapidly. Combination approaches (GLP-1 + resmetirom) are being explored.

References:
[1] Newsome PN, et al. N Engl J Med. 2021;384(12):1113-1124.
Last edited: May 18, 2026 at 2:58 PM
48 18NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 45 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
May 18, 2026 at 8:26 PM#8
SarahChen_PharmD said:
Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

Coming at SarahChen_PharmD’s question from a different direction. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Last edited: May 18, 2026 at 9:26 PM
47 17Dr.EndoEP, GraceAZ_72, carl_compliance and 44 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
May 19, 2026 at 5:54 AM#9

One thing that is still open after MikeFit_NJ’s answer:

What did you change at the same time, and can you separate the two now?

46 16ricardo_MIA, BrianDallas92, labquiet_amy and 43 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
May 21, 2026 at 3:23 AM#10

OP back with an update, since a thread like this is useless without one.

Update: the thing I was blaming turned out not to be the cause. Leaving the original post as written rather than editing it, so the mistake stays visible for whoever searches this next.

Last edited: May 21, 2026 at 6:23 AM
26 24wanda_boise, NurseAsh_DET, BenResearch_OR and 23 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register